Cita APA (7a ed.)
Bartoszko, J., Schroer, J., Cappello, B., Iyengar, S., Goldkuhle, M., Skoetz, N., . . . Moja, L. (2026). Evidence-to-Decision Framework to Prioritize PD-1 and PD-L1 Immune Checkpoint Inhibitors for the WHO Model List of Essential Medicines to Treat Adults with Solid Tumors in the Palliative First-Line Setting: Pilot Study. WHO Drug Information, 40(2), 275-284.
Cita Chicago Style (17a ed.)
Bartoszko, Jessica, Julia Schroer, Bernadette Cappello, Swathi Iyengar, Marius Goldkuhle, Nicole Skoetz, Mario Csenar, y Lorenzo Moja. "Evidence-to-Decision Framework to Prioritize PD-1 and PD-L1 Immune Checkpoint Inhibitors for the WHO Model List of Essential Medicines to Treat Adults with Solid Tumors in the Palliative First-Line Setting: Pilot Study." WHO Drug Information 40, no. 2 (2026): 275-284.
Cita MLA (9a ed.)
Bartoszko, Jessica, et al. "Evidence-to-Decision Framework to Prioritize PD-1 and PD-L1 Immune Checkpoint Inhibitors for the WHO Model List of Essential Medicines to Treat Adults with Solid Tumors in the Palliative First-Line Setting: Pilot Study." WHO Drug Information, vol. 40, no. 2, 2026, pp. 275-284.
Precaución: Estas citas no son 100% exactas.